Perbedaan Organon Pharma Indonesia Tbk. dan Ulima Nitra Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Ulima Nitra Tbk. diperdagangkan di Rp121 (kapitalisasi pasar 382,96 M, volume 24 jam 2,01 jt). Perbedaan utamanya: Ulima Nitra Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UNIQ | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 382,96 M |
Volume | — | 2,01 jt |
Lot | — | 20,11 rb |
Perputaran | — | 243,4 jt |
Harga Rata-rata | — | 121,02 |
Nilai Transaksi | — | 243,4 jt |
Harga Ekuilibrium Indikatif | — | 121 |
Volume Ekuilibrium Indikatif | — | 757 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Ulima Nitra Tbk (the Company) was established based on Notarial Deed No. 74 dated August 25, 1992 of Heniwati Ridwan, S.H., a public notary in Palembang. The Company started its commercial operations in 1992.
Selengkapnya di halaman UNIQ →